Dong Wei is the founder of EdiGene. EdiGene has raised $129M in total funding. Latest round: Series B. Based in Cambridge, USA.
Dong Wei is the CEO of EdiGene, a Chinese biotech company that specializes in gene-editing technologies. The company is advancing its pipeline of gene-editing therapeutics into clinics, focusing on genetic diseases and cancer. EdiGene has successfully raised significant funding, including a Series B-plus round of $62 million in April 2021 and a Series B round of $67 million in October 2020.
Full founder directory · Investor directory · Company funding database · Fundraising library